Pulse Alternative
Equities

Universal Health Services (UHS) Stock Looks Undervalued As Shares Fell 29% YTD


Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

Universal Health Services stock has slipped around 29.2% year to date, yet the valuation checks still lean toward the shares looking inexpensive on several fronts. This raises a clear question about whether the recent weakness lines up with the fundamentals.

  • The roughly 29.2% decline year to date suggests sentiment has cooled sharply, even though longer term returns are less weak.

  • For a healthcare operator like Universal Health Services, expectations around patient volumes and pricing can support the valuation, while any sustained pressure on margins or higher capital spending needs may limit how much value investors are willing to ascribe.

  • The company screens as undervalued on most of Simply Wall St’s checks, with 5 out of 6 pointing to the shares looking cheap relative to fundamentals.

The issue now is whether that mix of a weak year to date share price and strong valuation score adds up to a genuine opportunity in Universal Health Services or simply reflects risks the market is already pricing in.

Find out why Universal Health Services’ 0.5% return over the last year is lagging behind its peers.

Does Universal Health Services Look Undervalued on Earnings?

The P/E ratio is a useful way to think about what you are paying today for each dollar of Universal Health Services earnings. On this measure, Universal Health Services trades on about 6.2x earnings, compared with a Healthcare industry average of roughly 25.9x and a peer group average around 21.5x, so the stock sits at a substantial discount to many listed healthcare operators.

The fair P/E ratio for Universal Health Services, based on its specific profile, is estimated at about 19.9x, which is more than three times the current multiple. That gap suggests the market is pricing the stock well below what this model indicates could be reasonable for a business in this sector with its characteristics, even after factoring in risks. While no single metric tells the full story, the P/E comparison points to investors paying relatively little for the company’s current earnings stream.

Taken together, these figures indicate that Universal Health Services stock appears to be trading at a low valuation on a P/E basis.

NYSE:UHS P/E Ratio as at Jul 2026
NYSE:UHS P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Universal Health Services Narrative: What Would Justify Today’s Price?

Simply Wall St Narratives take the valuation puzzle around Universal Health Services’ low P/E and turn it into clear scenarios that explain what would need to happen to growth, margins and earnings for the stock to be worth materially more or less than today’s price, hosted on the company’s Community page. Rather than focusing on a single multiple or model output, each narrative lays out the assumptions behind its fair value so you can compare them with actual results over time.

One of the top community narratives on Universal Health Services: 31% undervalued

“UHS operates one of the largest behavioral health hospital networks in the country, alongside a substantial acute care segment…”

Read one of the top narratives on Universal Health Services

Do you think there’s more to the story for Universal Health Services? Head over to our Community to see what others are saying!

The Bottom Line

Universal Health Services looks undervalued on traditional earnings multiples, which suggests the market is applying a cautious stance to its current profit stream. For you, the key question is whether the discount fairly reflects concerns around margins, capital needs and sentiment toward healthcare operators, or whether it has become too wide. The crux of the debate from here is whether Universal Health Services can sustain earnings that eventually support a higher P/E, or if the current pricing simply matches the business risk profile more closely than the raw valuation signals imply.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include UHS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Related posts

Is Option Care Health, Inc. (OPCH) A Good Stock To Buy Now?

George

Saskatchewan invests $43M in healthcare IT infrastructure

George

2 Financials Stocks Worth Investigating and 1 We Ignore

George

Leave a Comment